AD-MSC therapy(China Medical University Hospital)

N/A

Report date: 2024/08/29 20:00:20

Base Information

Drug NameAD-MSC therapy(China Medical University Hospital)

Drug Alias NameADSC01ADSC-01

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Donor > Allogeneic

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsConnective Tissue DiseasesLung Diseases, Interstitial

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesChina Medical University Hospital

China Registration ClassN/A

Develop Information

Active CompaniesChina Medical University Hospital

Inactive CompaniesN/A

Active IndicationsConnective Tissue DiseasesLung Diseases, Interstitial

Inactive IndicationsN/A

Other Information

ATC CodeN/A